EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial

Ann-Sophie Page, Jan Y Verbakel, Johan Verhaeghe, Yani P Latul iD, Susanne Housmans, Jan Deprest iD

BJOG: An International Journal of Obstetrics & Gynaecology · 2023-02 · 130 (3) · 312-319

DOI: 10.1111/1471-0528.17335 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 15.11.2022. Verfasst von Ann-Sophie Page und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department Obstetrics and Gynaecology, Pelvic Floor Unit, University Hospitals KU Leuven, and Academic Department Development and Regeneration, Clust…. Hauptthemen laut MEDLINE: Vaginal Diseases, Lasers, Gas, Laser Therapy. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess whether CO 2 laser treatment is more effective than sham application in relieving the most bothersome symptom (MBS) in women with genitourinary syndrome of menopause (GSM).

Design

Single‐centre, sham‐controlled, double‐blind, randomised trial.

Setting

A tertiary centre in Belgium. Population Sixty women with moderate to severe GSM symptoms.

Methods

All participants eventually received three consecutive laser and three consecutive sham applications, either first laser followed by sham, or conversely. Main outcome measures The primary outcome was the participant‐reported change in severity of the MBS at 12 weeks. Secondary outcomes included subjective (patient satisfaction, sexual function, urinary function) and objective (pH, Vaginal Health Index Score, in vivo microscopy) measurements assessing the short‐term effect and the longevity of treatment effects at 18 months after start of the therapy. Adverse events were reported at every visit.

Results

The MBS severity score decreased from 2.86 ± 0.35 to 2.17 ± 0.93 (−23.60%; 95% CI −36.10% to −11.10%) in women treated with laser compared with 2.90 ± 0.31 to 2.52 ± 0.78 (−13.20%; 95% CI −22.70% to −3.73%) in those receiving sham applications ( p = 0.13). There were no serious adverse events reported up to 18 months.

Conclusions

In women with GSM, the treatment response 12 weeks after laser application was comparable to that of sham applications. There were no obvious differences for secondary outcomes and no serious adverse events were reported.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaginal DiseasesLasers, GasLaser TherapyHumansFemaleMenopauseSyndromeVaginaTreatment Outcome

Stichwörter der Autor:innen

atrophymenopauseplaceborandomised controlled trialvaginal laser therapy

Autor:innen und Institutionen

  • Department Obstetrics and Gynaecology, Pelvic Floor Unit, University Hospitals KU Leuven, and Academic Department Development and Regeneration, Cluster Urogenital Surgery, KU Leuven, Leuven, Belgium.
  • Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
  • Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Department Obstetrics and Gynaecology, University Hospitals Leuven, and Academic Department Development and Regeneration, Cluster Urogenital Surgery, KU Leuven, Leuven, Belgium.
  • Department of Obstetrics and Gynaecology, Amsterdam Reproduction & Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: Yani P Latul, Jan Deprest

Zitieren

APA

Page, A. S., Verbakel, J. Y., Verhaeghe, J., Latul, Y. P., Housmans, S., & Deprest, J. (2023). Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology, 130(3), 312-319. https://doi.org/10.1111/1471-0528.17335

Vancouver

Page AS, Verbakel JY, Verhaeghe J, Latul YP, Housmans S, Deprest J. Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology. 2023;130(3):312-319. doi:10.1111/1471-0528.17335

BibTeX
@article{Page2023,
  author = {Page, Ann-Sophie and Verbakel, Jan Y and Verhaeghe, Johan and Latul, Yani P and Housmans, Susanne and Deprest, Jan},
  title = {Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2023},
  volume = {130},
  number = {3},
  pages = {312--319},
  doi = {10.1111/1471-0528.17335}
}
Kostenlos starten →